Freeline TX

Freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a next-generation AAV gene therapy platform developed by Amit Nathwani, Professor of Haematology at UCL and CSO of Freeline Therapeutics.

The Challenge

The Solution

Testimonial to follow...
Dr Jane Whitrow Vice President

The Tech

Emerging Tech

The Stats

Ready to work WIth Us?

Contact us